PagrindinisLILY34 • BVMF
add
Eli Lilly and Company
Ankstesnė uždarymo kaina
153,98 R$
Dienos intervalas
151,21 R$ - 156,03 R$
Metų intervalas
91,08 R$ - 181,98 R$
Bendroji vertė rinkoje
709,08 mlrd. USD
Vidutinė prekybos apimtis
34,25 tūkst.
Aktualios naujienos
Finansiniai rodikliai
Pajamų ataskaita
Pajamos
Grynosios pajamos
(USD) | 2024-09info | Metinis pokytis |
---|---|---|
Pajamos | 11,44 mlrd. | 20,43 % |
Veiklos sąnaudos | 4,72 mlrd. | 15,16 % |
Grynosios pajamos | 970,30 mln. | 1 790,42 % |
Grynojo pelno marža | 8,48 | 1 513,33 % |
Pelnas tenkantis vienai akcijai | 1,18 | 1 080,00 % |
EBITDA | 5,02 mlrd. | 26,94 % |
Taikomas mokesčio tarifas | 38,91 % | — |
Balansas
Visas turtas
Visi įsipareigojimai
(USD) | 2024-09info | Metinis pokytis |
---|---|---|
Lėšos, trump. investicijos | 3,52 mlrd. | 34,11 % |
Visas turtas | 75,61 mlrd. | 30,55 % |
Visi įsipareigojimai | 61,29 mlrd. | 31,49 % |
Visos paprastosios akcijos | 14,32 mlrd. | — |
Išleistos akcijos | 899,32 mln. | — |
Kaina / apskaitinė vertė | 9,73 | — |
Turto grąža | 15,42 % | — |
Kapitalo grąža | 25,79 % | — |
Pinigų srautas
Grynasis pokytis (grynaisiais pinigais)
(USD) | 2024-09info | Metinis pokytis |
---|---|---|
Grynosios pajamos | 970,30 mln. | 1 790,42 % |
Pinigai iš operacijų | 3,71 mlrd. | 69,53 % |
Pinigai iš investicijų | −4,00 mlrd. | −30,00 % |
Pinigai iš finansavimo | 211,30 mln. | −63,06 % |
Grynasis pokytis (grynaisiais pinigais) | 145,40 mln. | 146,35 % |
Laisvas pinigų srautas | −889,81 mln. | −161,21 % |
Apie
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union Army veteran of the American Civil War for whom the company was later named.
As of October 2024, Lilly is the most valuable drug company in the world with a $842 billion market capitalization, the highest valuation ever achieved to date by a drug company. The company is ranked 127th on the Fortune 500 with revenue of $34.12 billion. It is ranked 221st on the Forbes Global 2000 list of the world's largest publicly-traded companies and 252nd on Forbes' list of "America's Best Employers". It is recognized as the top entry-level employer in Indianapolis.
Lilly is known for its clinical depression drugs Prozac, Cymbalta, and its antipsychotic medication Zyprexa. The company's primary revenue drivers are the diabetes drugs Humalog and Trulicity.
Lilly was the first company to mass-produce both the polio vaccine, developed in 1955 by Jonas Salk, and insulin. Wikipedia
Generalinis direktorius
Įkurta
1876
Pagrindinė būstinė
Svetainė
Darbuotojų skaičius
43 000